Insider Actions for Context Therapeutics Inc.
12/16/2021 |
Martin A. Lehr Chief Executive Officer; Director |
13,000 | Acquisition at $3.22 per share. | 41,860 |
10/22/2021 |
Martin A. Lehr Chief Executive Officer; Director |
10,000 | Acquisition at $5 per share. | 50,000 |
10/22/2021 |
Martin A. Lehr Chief Executive Officer; Director |
10,000 | Acquisition at $5 per share. | 50,000 |
10/22/2021 |
Alex Levit Chief Legal Officer, Corp. Sec |
3,000 | Acquisition at $5 per share. | 15,000 |
10/22/2021 |
Martin A. Lehr Chief Executive Officer; Director |
586,475 | Derivative/Non-derivative trans. at $0 per share. | 0 |
10/22/2021 |
Martin A. Lehr Chief Executive Officer; Director |
210,715 | Derivative/Non-derivative trans. at $0 per share. | 0 |
10/22/2021 |
Martin A. Lehr Chief Executive Officer; Director |
586,476 | Derivative/Non-derivative trans. at $0 per share. | 0 |
10/22/2021 |
Martin A. Lehr Chief Executive Officer; Director |
210,722 | Derivative/Non-derivative trans. at $0 per share. | 0 |
10/22/2021 |
Evan G. Dick SVP of R&D |
26,587 | Derivative/Non-derivative trans. at $0 per share. | 0 |
10/22/2021 |
Evan G. Dick SVP of R&D |
26,587 | Derivative/Non-derivative trans. at $0 per share. | 0 |
10/22/2021 |
Martin A. Lehr Chief Executive Officer; Director |
52,680 | 376,135 | |
10/22/2021 |
Martin A. Lehr Chief Executive Officer; Director |
52,680 | 376,135 |